Home
Lind Global Fund III reported a 6.4% stake in Silexion Therapeutics SLXN · 212,500 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 6.4%
- Last report
- 9.9% · filed 25/09/18
- Shares held
- 212,500 sh
- Class
- Ordinary shares, par value $0.0135 per share
- Holder
- Lind Global Fund III
- Event date
- 25/09/30
- Filed
- 25/11/14
6.4% stake · −3.5pp from the last report
- Stake
- 6.4%
- Last report
- 9.9%
- Since last report
- −3.5pp
Silexion Therapeutics trades, last 26 weeks
What else happened in Silexion Therapeutics around then
Filed or reported within 30 days of the trade day · 25/08/31~25/10/30Lind Global Fund III's other 5% stake reports
- Lind Global Fund III
5% stakeDare Bioscience
5% stakeDare Bioscience
DARE
5.65% stake
1,094,890 sh
5.65% stake
Filed 08/28
- Lind Global Fund III
5% stakeDefsec Technologies
5% stakeDefsec Technologies
DFSC
9.99% stake
347,315 sh
9.99% stake
Filed 08/25
- Lind Global Fund III
5% stakeEnveric Biosciences
5% stakeEnveric Biosciences
ENVB
1.4% stake
51,866 sh
1.4% stake
Filed 08/14
- Lind Global Fund III
5% stakeNuwellis
5% stakeNuwellis
NUWE
6.2% stake
193,050 sh
6.2% stake
Filed 08/05
- Lind Global Fund III
5% stake60 Degrees Pharmaceuticals
5% stake60 Degrees Pharmaceuticals
SXTP
5.45% stake
191,571 sh
5.45% stake
Filed 08/05
